These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11246695)

  • 1. Minimal clinically important difference module: summary, recommendations, and research agenda.
    Wells G; Anderson J; Beaton D; Bellamy N; Boers M; Bombardier C; Breedveld F; Carr A; Cranney A; Dougados M; Felson D; Kirwan J; Schiff M; Shea B; Simon L; Smolen J; Strand V; Tugwell P; van Riel P; Welch VA
    J Rheumatol; 2001 Feb; 28(2):452-4. PubMed ID: 11246695
    [No Abstract]   [Full Text] [Related]  

  • 2. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
    Beaton DE; Bombardier C; Katz JN; Wright JG; Wells G; Boers M; Strand V; Shea B
    J Rheumatol; 2001 Feb; 28(2):400-5. PubMed ID: 11246687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimum clinically important difference: the crock of gold at the end of the rainbow?
    Kirwan JR
    J Rheumatol; 2001 Feb; 28(2):439-44. PubMed ID: 11246693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is minimal clinically important difference relevant for the interpretation of clinical trials in pediatric rheumatic diseases?
    Ruperto N
    J Rheumatol; 2007 Mar; 34(3):463-5. PubMed ID: 17343299
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal clinically important differences: review of methods.
    Wells G; Beaton D; Shea B; Boers M; Simon L; Strand V; Brooks P; Tugwell P
    J Rheumatol; 2001 Feb; 28(2):406-12. PubMed ID: 11246688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatology, a clinical overview.
    Whisler RL; Gray LS; Hackshaw KV
    Clin Podiatr Med Surg; 2002 Jan; 19(1):149-61, vii. PubMed ID: 11806162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing rheumatic and musculoskeletal diseases - past, present and future.
    Burmester GR; Bijlsma JWJ; Cutolo M; McInnes IB
    Nat Rev Rheumatol; 2017 Jul; 13(7):443-448. PubMed ID: 28615732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative practices in rheumatology.
    Ramos-Remus C; Raut A
    Best Pract Res Clin Rheumatol; 2008 Aug; 22(4):741-57. PubMed ID: 18783748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based medicine and the Cochrane Collaboration.
    Tanjong-Ghogomu E; Tugwell P; Welch V
    Bull NYU Hosp Jt Dis; 2009; 67(2):198-205. PubMed ID: 19583554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are we failing patients in our assessment of treatment failure?
    Nikiphorou E; Aletaha D; Bukhari M
    Rheumatology (Oxford); 2019 Apr; 58(4):561-562. PubMed ID: 29897585
    [No Abstract]   [Full Text] [Related]  

  • 11. General Practitioners and Rheumatologists: new bridges for a successful cooperation.
    Pereira da Silva JA; Cernadas R; Canas da Silva J
    Acta Reumatol Port; 2017; 42(1):6-7. PubMed ID: 28371570
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Burmester GR
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S2. PubMed ID: 26536183
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring outcomes.
    Keller RB
    J Orthop Res; 1996 Mar; 14(2):171-2. PubMed ID: 8648492
    [No Abstract]   [Full Text] [Related]  

  • 14. Principles of management of musculoskeletal conditions in children and young people.
    Davis PJ; McDonagh JE
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):263-78. PubMed ID: 16546056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Strangfeld A
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S3-4. PubMed ID: 26536188
    [No Abstract]   [Full Text] [Related]  

  • 16. The spectrum of paediatric and adolescent rheumatology.
    Davies K; Copeman A
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):179-200. PubMed ID: 16546052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to manage rheumatic and musculoskeletal diseases - Preface.
    Stamm T; Moe RH
    Best Pract Res Clin Rheumatol; 2020 Apr; 34(2):101568. PubMed ID: 32762938
    [No Abstract]   [Full Text] [Related]  

  • 18. MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.
    Wells G; Anderson J; Boers M; Felson D; Heiberg T; Hewlett S; Johnson K; Kirwan J; Lassere M; Robinson V; Shea B; Simon L; Strand V; van Riel P; Tugwell P
    J Rheumatol; 2003 May; 30(5):1115-8. PubMed ID: 12734920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell therapies : New options in the treatment of rheumatic and musculoskeletal diseases].
    Alexander T; Burmester G
    Z Rheumatol; 2020 Jun; 79(5):417-418. PubMed ID: 32494983
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
    Kitas GD; Dimitroulas T
    Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.